CHA Biotech Co. Ltd

Chabiotech Co., Ltd. is a bio company that develops cell and gene therapies related to stem and immune cells in South Korea and internationally. It provides umbilical cord blood consignment storage for incurable diseases, regenerative medicines, immune cell and stem cell storage services, anti-aging solutions, and medical wellness programs. The company also offers customized development, production, clinical, and commercialization services, as well as IT system construction and consulting for the Chaum model. Additionally, it develops immune cell therapies such as CBT101 for recurrent glioblastoma and solid cancer, CBT111 and CAR-NK for solid cancer, and stem cell therapies including CordSTEM-DD for chronic back pain, CordSTEM-POI for premature ovarian failure, CordSTEM-ST for stroke, CBT-NPC for Parkinson's disease, and hESC-RPE for macular degeneration and Stargardt's disease. Other services include IVF, cosmetics, medical devices, bioinsurance storage, and research services. Founded in 2002, the company is headquartered in Seoul, South Korea.